Drug Standards of China 2025;26(1):023-027
doi:10.19778/j.chp.2025.01.004
Introduction of the main addition and revision of the Chinese Pharmacopoeia 2025 Edition(Volume Ⅱ)
ZHOU Yi ; WANG Zhijun ; YUE Zhihua ; CHENG Qilei ; YUE Ruiqi ; YANG Xi ; GUO Wei ; MA Shuangcheng
Keywords
The Chinese Pharmacopoeia 2025 Edition (Volume Ⅱ) (ChP 2025,Volume Ⅱ); the addition and revision of drug monographs; drug standard
Country
China
Language
Chinese
Abstract
The Pharmacopeia of the People’s Republic of China 2025 Edition (referred to as the Chinese Pharmacopoeia 2025 Edition, ChP 2025) will be promulgated and implemented. This article introduces the process of development of ChP 2025 Edition (Volume Ⅱ), including the selection, the revision of general notices,the addition and revision of drug monographs, etc., and provides some analysis and examples to illustrate,which can facilitate the readers to understand and implement the ChP 2025 Edition (Volume Ⅱ).
备案号: 11010502037788, 京ICP备10218182号-8)